Medical Oncologist Joins USA Health Mitchell Cancer Institute
MOBILE, Alabama (8/22/22) -- USA Health is expanding its oncology care team with the addition of Nabin R. Karki, M.D., a fellowship-trained medical oncologist and hematologist who sees patients at the USA Health Mitchell Cancer Institute, the region’s only academic cancer treatment center.
Karki, also an assistant professor of interdisciplinary clinical oncology, specializes in the treatment of genitourinary cancers, which are malignancies found in the urinary system and the male reproductive system. He will focus on prostate cancer, kidney cancer, bladder cancer and testicular cancer.
“Patients are at the center of our cancer care program,” Karki said. “You can expect a collaborative approach wherein my team and I will work with each patient to provide individualized, evidence-based, comprehensive care.”
Karki completed a fellowship in hematology and medical oncology at the Medical College of Georgia at Augusta University in Augusta, Georgia. He completed a residency in internal medicine at MedStar Health in Baltimore, Maryland. He received his medical degree from B.P. Koirala Institute of Health Sciences in Dharan, Nepal.
Karki said he is eager to join an academic health system. “I strongly believe in a multidisciplinary approach and would like to make clinical trials accessible and available to my patients,” he said. “In addition, I enjoy sharing my knowledge with trainees.”
Among his research interests are castrate-resistant prostate cancer, kidney cancer, adjuvant therapy, immunotherapy, and health services and outcomes.
###
About the Mitchell Cancer Institute
The USA Health Mitchell Cancer Institute stands as the only academic cancer treatment and research facility along the upper Gulf Coast. Continuous research and technological advancements keep the MCI at the forefront of cancer treatment and outcomes. Providers and staff are dedicated to bringing the most advanced care to people in the region, including having available clinical trials that are the steppingstones to widespread treatment options.
